skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Increased inflammation in sanctuary sites may explain viral blips in HIV infection

Journal Article · · IET Systems Biology
 [1];  [2];  [3]
  1. Pennsylvania State Univ., Malvern, PA (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Univ. of Delaware, Newark, DE (United States)
  3. Univ. of Delaware, Newark, DE (United States)

Here, combined antiretroviral therapy (cART) suppress HIV-1 viral replication, such that viral load in plasma remains below the limit of detection in standard assays. However, intermittent episodes of transient viremia (blips) occur in a set of HIV-patients. Given that follicular hyperplasia occurs during lymphoid inflammation as a normal response to infection, it is hypothesised that when the diameter of the lymph node follicle (LNF) increases and crosses a critical size, a viral blip occurs due to cryptic viremia. To study this hypothesis, a theoretical analysis of a mathematical model is performed to find the conditions for virus suppression in all compartments and different scenarios of LNF size changes are simulated. According to the analysis, blips with duration of around 30 days arise when the diameter rise rate is between 0.02 and 0.03 days–1. Moreover, the final diameter of the site is directly related to the steady states of the virus load after the occurrence of a blip. When the value of R0 is around 2.1, to have a steady-state below the limit of detection after the viral blip, the maximum final diameters should be greater than 0.7 mm so that there is a relative loss of connection between compartments.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1255268
Report Number(s):
LA-UR-16-20164
Journal Information:
IET Systems Biology, Journal Name: IET Systems Biology; ISSN 1751-8849
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 2 works
Citation information provided by
Web of Science

References (51)

A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients journal April 2011
Follicular B helper T cells in antibody responses and autoimmunity journal November 2005
Proliferating Active Cells, Lymphocyte Subsets, and Dendritic Cells in Recurrent Tonsillitis: Their Effect on Hypertrophy journal May 2008
Blood Microcirculation in the Lymph node During the Primary Immune Response journal October 1972
Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART journal February 2005
Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART journal October 2011
Viral Blips May Not Need a Trigger: How Transient Viremia Can Arise in Deterministic In-Host Models journal January 2014
Tracking episomal HIV DNA: implications for viral persistence and eradication of HIV journal January 2013
Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis journal April 2012
Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial journal August 2013
Lymphoid Fibrosis Occurs in Long-Term Nonprogressors and Persists With Antiretroviral Therapy but May Be Reversible With Curative Interventions journal October 2014
Florid Reactive Follicular Hyperplasia in Elderly Patients. A Clinicopathological Study of 23 Cases journal January 1998
Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: A clinicopathological and immunohistological study of 21 cases journal April 2000
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient journal January 1999
The paradox of the immune response in HIV infection: When inflammation becomes harmful journal February 2013
Excitability in the host–pathogen interactions of HIV infection and emergence of viral load blips journal January 2013
Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy journal October 2009
Modeling HIV persistence, the latent reservoir, and viral blips journal September 2009
Lymphoid tissue viral burden and duration of viral suppression in plasma journal January 2001
Transient Viremia, Plasma Viral Load, and Reservoir Replenishment in HIV-Infected Patients on Antiretroviral Therapy journal January 2007
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy journal September 2005
Certifying spatially uniform behavior in reaction–diffusion PDE and compartmental ODE systems journal June 2011
Viral Blip Dynamics during Highly Active Antiretroviral Therapy journal November 2003
Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals: Immune activation and risk of viral blips journal February 2014
Influence of Episodes of Intermittent Viremia (“Blips”) on Immune Responses and Viral Load Rebound in Successfully Treated HIV-Infected Patients journal January 2013
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen journal January 2005
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence journal September 2004
Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients journal October 2014
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication journal September 2012
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial journal August 2010
Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients journal January 2010
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART journal January 2001
Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy journal November 2014
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy journal January 2012
Tissue Says Blood Is Misleading, Confusing HIV Cure Efforts journal December 2011
HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics journal July 2012
Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection journal October 2004
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues journal January 2014
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects journal March 2010
Benign lymphadenopathies journal January 2013
Short Communication: HIV Blips While on Antiretroviral Therapy Can Indicate Consistently Detectable Viral Levels Due to Assay Underreporting journal December 2013
Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients journal January 2003
Modelling HIV-1 2-LTR dynamics following raltegravir intensification journal July 2013
Viral Blip Dynamics during Highly Active Antiretroviral Therapy journal November 2003
Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection journal October 2004
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART journal January 2001
Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients journal January 2003
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient journal January 1999
Lymphoid tissue viral burden and duration of viral suppression in plasma journal January 2001
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification journal March 2014
Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: A clinicopathological and immunohistological study of 21 cases journal April 2000

Cited By (1)

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence journal January 2018